Literature DB >> 12458140

Antibacterial activity of moxifloxacin against periodontal anaerobic pathogens involved in systemic infections.

I Milazzo1, G Blandino, R Musumeci, G Nicoletti, A M Lo Bue, A Speciale.   

Abstract

The in vitro activity of moxifloxacin was compared with that of penicillin G, amoxycillin/clavulanate, cefoxitin, erythromycin, clindamycin and metronidazole against 158 isolates associated with periodontal infections. MIC(50)/MIC(90) values of moxifloxacin were respectively 0.06/0.5 mg/l for Porphyromonas gingivalis (35), for Prevotella spp. (28) and Actinomyces spp. (35), 0.12/0.25 mg/l for Fusobacterium nucleatum (20) and 0.06/0.12 mg/l for Peptostreptococcus spp. (30). The minimum inhibitory concentration (MIC) range of moxifloxacin for Bacteroides forsythus (6) and Campylobacter rectus (4) was 0.06-0.12 mg/l. The minimum bactericidal concentrations were equal to or 2-4 times the MIC values. Moxifloxacin produced a bactericidal effect at 8 h. Our results show that moxifloxacin has good antibacterial activity against periodontal pathogens comparable with that of cefoxitin and amoxycillin/clavulanate, and better than that of clindamycin, metronidazole and penicillin. Copyright 2002 Elsevier Science B.V. and International Society of Chemotherapy

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12458140     DOI: 10.1016/s0924-8579(02)00190-5

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  13 in total

1.  Comparative efficacies of amoxicillin, clindamycin, and moxifloxacin in prevention of bacteremia following dental extractions.

Authors:  P Diz Dios; I Tomás Carmona; J Limeres Posse; J Medina Henríquez; J Fernández Feijoo; M Alvarez Fernández
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

2.  Micromatricial metronidazole benzoate film as a local mucoadhesive delivery system for treatment of periodontal diseases.

Authors:  Amal Hassan El-Kamel; Lubna Y Ashri; Ibrahim A Alsarra
Journal:  AAPS PharmSciTech       Date:  2007-09-14       Impact factor: 3.246

3.  Clinical and microbiological efficacy of moxifloxacin versus amoxicillin/clavulanic acid in severe odontogenic abscesses: a pilot study.

Authors:  B Al-Nawas; C Walter; T Morbach; N Seitner; E Siegel; M Maeurer; F Krummenauer
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-07-29       Impact factor: 3.267

4.  Comparative efficacy and safety of moxifloxacin and clindamycin in the treatment of odontogenic abscesses and inflammatory infiltrates: a phase II, double-blind, randomized trial.

Authors:  Georg Cachovan; Rainer H Böger; Ina Giersdorf; Olaf Hallier; Thomas Streichert; Munif Haddad; Ursula Platzer; Gerhard Schön; Karl Wegscheider; Ingo Sobottka
Journal:  Antimicrob Agents Chemother       Date:  2010-12-20       Impact factor: 5.191

5.  Osteomyelitis of the jaw: resistance to clindamycin in patients with prior antibiotics exposure.

Authors:  C Pigrau; B Almirante; D Rodriguez; N Larrosa; S Bescos; G Raspall; A Pahissa
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-09-17       Impact factor: 3.267

6.  Activity of pradofloxacin against Porphyromonas and Prevotella spp. Implicated in periodontal disease in dogs: susceptibility test data from a European multicenter study.

Authors:  Bernd Stephan; Heinrich A Greife; Andrew Pridmore; Peter Silley
Journal:  Antimicrob Agents Chemother       Date:  2008-04-14       Impact factor: 5.191

7.  Fabrication and Appraisal of Poly (Lactic-Co-Glycolic Acid) - Moxifloxacin Nanoparticles using Vitamin E-TPGS: A Potential Intracanal Drug Delivery Agent.

Authors:  Hardik Makkar; Gaurav Patri
Journal:  J Clin Diagn Res       Date:  2017-06-01

8.  Bisphosphonates in dentistry: Historical perspectives, adverse effects, and novel applications.

Authors:  Parish P Sedghizadeh; Shuting Sun; Allan C Jones; Esmat Sodagar; Philip Cherian; Casey Chen; Adam F Junka; Jeffrey D Neighbors; Charles E McKenna; R Graham G Russell; Frank H Ebetino
Journal:  Bone       Date:  2021-03-20       Impact factor: 4.626

9.  Systemic moxifloxacin vs amoxicillin/metronidazole adjunct to non-surgical treatment in generalized aggressive periodontitis.

Authors:  Esra Guzeldemir-Akcakanat; Cem-Abdulkadir Gurgan
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2015-07-01

10.  Moxifloxacin versus Clindamycin/Ceftriaxone in the management of odontogenic maxillofacial infectious processes: A preliminary, intrahospital, controlled clinical trial.

Authors:  Hansel Gómez-Arámbula; Antonio Hidalgo-Hurtado; Rosaura Rodríguez-Flores; Ana-María González-Amaro; Arturo Garrocho-Rangel; Amaury Pozos-Guillén
Journal:  J Clin Exp Dent       Date:  2015-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.